MINT-FAMOTIDINE TABLET

국가: 캐나다

언어: 영어

출처: Health Canada

지금 구매하세요

Download 제품 특성 요약 (SPC)
07-06-2023

유효 성분:

FAMOTIDINE

제공처:

MINT PHARMACEUTICALS INC

ATC 코드:

A02BA03

INN (국제 이름):

FAMOTIDINE

복용량:

40MG

약제 형태:

TABLET

구성:

FAMOTIDINE 40MG

관리 경로:

ORAL

패키지 단위:

100

처방전 유형:

Prescription

제품 요약:

Active ingredient group (AIG) number: 0118722002; AHFS:

승인 상태:

APPROVED

승인 날짜:

2023-06-23

제품 특성 요약

                                Page 1 of 26
PRODUCT MONOGRAPH
PR
MINT-
FAMOTIDINE
Famotidine Tablets 20 mg and 40 mg
USP
Histamine H
2
Receptor Antagonist
Mint Pharmaceuticals Inc.
6575 Davand Drive
Mississauga, Ontario
L5T 2M3
Date of Revision:
June 7, 2023
Submission Control Number: 267823
Page 2 of 26
PRODUCT MONOGRAPH
Pr
MINT-FAMOTIDINE
Famotidine Tablets 20 mg and 40 mg
THERAPEUTIC CLASSIFICATION
Histamine H
2
Receptor Antagonist
ACTION AND CLINICAL PHARMACOLOGY
Famotidine is a competitive inhibitor of histamine H
2
receptors. The primary clinically
important
pharmacologic activity of famotidine is inhibition of gastric juice
secretion. Famotidine reduces
the acid and pepsin content, as well as the volume, of basal,
nocturnal, and stimulated gastric
secretion.
COMPARATIVE BIOAVAILABILITY STUDIES
A double-blind, randomized, two-treatment, single-dose, crossover oral
bioequivalence study of
MINT-FAMOTIDINE 40 mg tablets (Mint Pharmaceuticals Inc.) and
Pr
TEVA-FAMOTIDINE
40 mg tablets (Teva Canada Limited) was conducted in healthy, adult
subjects under fasting
condition. A summary of the comparative bioavailability data from the
30 subjects included in
the statistical analysis is presented in the following table:
Page 3 of 26
SUMMARY TABLE OF THE COMPARATIVE BIOAVAILABILITY DATA
Famotidine
(1 x 40 mg famotidine)
Geometric Mean
Arithmetic Mean (CV %)
Parameter
Test
1
Reference
2
% Ratio of
Geometric
Means
90% Confidence
Interval
AUC
T
(ng·h/mL)
723.42
746.47 (23.73)
756.54
775.48 (21.70)
95.6
91.5 – 99.9
AUC
I
(ng·h/mL)
744.65
767.16 (23.20)
775.41
794.66 (21.66)
96.0
92.0 – 100.2
C
max
(ng/mL)
112.15
115.82 (25.54)
119.11
123.07 (26.23)
94.2
88.3 – 100.4
T
max
3
(h)
2.25
(1.00- 5.00)
2.13
(0.67- 5.00)
T
1/2
4
(h)
5.02 (19.52)
4.66 (15.55)
1
MINT-FAMOTIDINE (famotidine) tablets, 40 mg (Mint Pharmaceuticals
Inc.).
2 Pr
TEVA-FAMOTIDINE (famotidine) tablets, 40 mg (Teva Canada Limited).
3
Expressed the median (range) only.
4
Expressed as the arithmetic mean (CV%) only.
INDICATIONS AND CLINICAL USE
MINT-FAMOTIDINE is indicated in the trea
                                
                                전체 문서 읽기
                                
                            

다른 언어로 된 문서

제품 특성 요약 제품 특성 요약 프랑스어 07-06-2023

이 제품과 관련된 검색 알림